GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

Symbol: ATXS
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$14,059,434	1,073,766	+115,522	+12%	$13.09	Q4 2025
30 Sep 2025	0%	-0%	$6,977,524	958,244	-5,694	-0.59%	$7.28	Q3 2025
30 Jun 2025	0%	-0%	$5,167,733	963,938	-15,657	-1.6%	$5.36	Q2 2025
31 Mar 2025	0%	+0%	$5,232,277	979,595	+29,198		$5.34	Q1 2025
31 Dec 2024	0%	-0%	$8,498,617	950,397	-2,770	-0.29%	$8.94	Q4 2024
30 Sep 2024	0%	-0%	$10,496,420	953,167	-60,423	-6%	$11.01	Q3 2024
30 Jun 2024	0%	+0%	$9,225,825	1,013,590	+11,846	+1.2%	$9.10	Q2 2024
31 Mar 2024	0%	+0%	$14,101,253	1,001,744	+304,529	+44%	$14.08	Q1 2024
31 Dec 2023	0%	+0%	$5,355,070	697,215	+198,367	+40%	$7.68	Q4 2023
30 Sep 2023	0%	+0%	$3,721,897	498,848	+30,870	+6.6%	$7.46	Q3 2023
30 Jun 2023	0%	+0%	$3,898,256	467,978	+234,142	+100%	$8.33	Q2 2023
31 Mar 2023	0%	+0%	$3,110,018	233,836	+110,143	+89%	$13.30	Q1 2023
31 Dec 2022	0%	+0%	$1,841,000	123,693	+11,788	+11%	$14.88	Q4 2022
30 Sep 2022	0%	+0%	$1,011,000	111,905	+27,709	+33%	$9.03	Q3 2022
30 Jun 2022	0%	+0%	$252,000	84,196	+6,089	+7.8%	$2.99	Q2 2022
31 Mar 2022	0%	+0%	$524,000	78,107	+13,093	+20%	$6.71	Q1 2022
31 Dec 2021	0%	+0%	$350,000	65,014	+4,484	+7.4%	$5.38	Q4 2021
30 Sep 2021	0%	+0%	$535,000	60,530	+60,530	NEW	$8.84	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.